Das Harnblasenkarzinom im Fokus
Bastian Keck(Friedrich-Alexander-Universität Erlangen-Nürnberg), Roman Nawroth(TUM Klinikum), Martin Hoffmann(Research Centre of Medical Technology and Biotechnology), Arndt Hartmann(Universitätsklinikum Erlangen), Sebastian C. Schmid(TUM Klinikum), Robert Stöhr(Friedrich-Alexander-Universität Erlangen-Nürnberg), P. Olbert(Philipps University of Marburg), S. Füssel(German Cancer Research Center), Axel S. Merseburger(Universitäres Kinderwunschzentrum Lübeck)
Cited by 1
Related Papers
Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a<i>BRCA1</i>or<i>BRCA2</i>Gene Alteration
|Journal of Clinical Oncology|2020|676
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|660
Patterns of p53 Mutations Separate Ovarian Serous Borderline Tumors and Low- and High-grade Carcinomas and Provide Support for a New Model of Ovarian Carcinogenesis
|The American Journal of Surgical Pathology|2005|411
Dose-Response Association of CD8<sup>+</sup> Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer
|JAMA Oncology|2017|409
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
|Nature Communications|2021|386